{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:28:20Z","timestamp":1790422100987,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012860","name":"Comprehensive Cancer Center at Wake Forest Baptist Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ebiom.2019.05.034","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T06:58:05Z","timestamp":1559285885000},"page":"209-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2\u202fT-type voltage-gated calcium channels and Ca2+ influx"],"prefix":"10.1016","volume":"44","author":[{"given":"Hugo","family":"Jimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn W.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambad","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Surratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Brezovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Absher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"DeYoung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Wen","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Kuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwayne W.","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Ghanekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Capstick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Ralph B.","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Munden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Barbault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur W.","family":"Blackstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kounosuke","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl F.","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-7898","authenticated-orcid":false,"given":"Boris C.","family":"Pasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.05.034_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3322\/caac.21402","article-title":"Disparities in liver cancer occurrence in the United States by race\/ethnicity and state. CA","volume":"67","author":"Islami","year":"2017","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Global Burden of Disease Cancer, C","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0030","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u03b1-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","author":"Zhu","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2741\/4591","article-title":"Use of non-ionizing electromagnetic fields for the treatment of cancer","volume":"23","author":"Jimenez","year":"2018","journal-title":"Front Biosci (Landmark edition)"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-28-51","article-title":"Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach","volume":"28","author":"Barbault","year":"2009","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/bjc.2011.523","article-title":"Cancer cell proliferation is inhibited by specific modulation frequencies","volume":"106","author":"Zimmerman","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0050","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/bjc.2011.292","article-title":"Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields","volume":"105","author":"Costa","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5732\/cjc.013.10177","article-title":"Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies","volume":"32","author":"Zimmerman","year":"2013","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0060","first-page":"19","article-title":"TheraBionic P1 device receives European regulatory approval","volume":"44","author":"Goldberg","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0065","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/bem.21969","article-title":"An HF exposure system for mice with improved efficiency","volume":"37","author":"Capstick","year":"2016","journal-title":"Bioelectromagnetics"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0075","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1088\/0031-9155\/59\/18\/5287","article-title":"Development of a new generation of high-resolution anatomical models for medical device evaluation: the virtual population 3.0","volume":"59","author":"Gosselin","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0080","article-title":"Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0090","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","article-title":"RNA-SeQC: RNA-seq metrics for quality control and process optimization","volume":"28","author":"DeLuca","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/1471-2105-12-480","article-title":"GC-content normalization for RNA-Seq data","volume":"12","author":"Risso","year":"2011","journal-title":"BMC Bioinforma"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0110","series-title":"IEEE standards for safety levels with respect to human exposure to radio frequency electromagnetic fields, 3 kHz to 300 GHz, IEEE C95.1\u20132005","author":"IEEE","year":"2006"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0115","first-page":"494","article-title":"Guidelines for limiting exposure to time-varying electric, magnetic and electromagnetic fields (up to 300 GHz)","volume":"74","author":"ICNIRP","year":"1998","journal-title":"Health Phys"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2006.03.018","article-title":"Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice","volume":"45","author":"Schnater","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0125","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/hep.23892","article-title":"Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis","volume":"52","author":"Sharma","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0130","doi-asserted-by":"crossref","DOI":"10.3791\/50544-v","article-title":"Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice","author":"Ahmed","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0140","series-title":"Calcium entry pathways in non-excitable cells","first-page":"3","author":"Albarran","year":"2016"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/bem.2250010304","article-title":"Induction of calcium-ion efflux from brain tissue by radiofrequency radiation","volume":"1","author":"Blackman","year":"1980","journal-title":"Bioelectromagnetics"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1749-6632.1975.tb35984.x","article-title":"Effects of modulated VHF fields on the central nervous system","volume":"247","author":"Bawin","year":"1975","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmed.2010.01.005","article-title":"Ion channels and the hallmarks of cancer","volume":"16","author":"Prevarskaya","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrc3105","article-title":"Calcium in tumour metastasis: new roles for known actors","volume":"11","author":"Prevarskaya","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0170","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0026-895X(24)12522-9","article-title":"Block of cloned human T-type calcium channels by succinimide antiepileptic drugs","volume":"60","author":"Gomora","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0185","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","article-title":"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma","volume":"24","author":"Abou-Alfa","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2016.10.039","article-title":"At the crossroads of cancer stem cells and targeted therapy resistance","volume":"385","author":"Wang","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gutjnl-2015-309501","article-title":"Tumour initiating cells and IGF\/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma","volume":"66","author":"Tovar","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2015.11.034","article-title":"MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS\/RAF\/ERK signaling pathways","volume":"371","author":"Xu","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbmt.2006.10.010","article-title":"Cancer stem cells: from bench to bedside","volume":"13","author":"Jones","year":"2007","journal-title":"Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0215","doi-asserted-by":"crossref","first-page":"e3017","DOI":"10.1038\/cddis.2017.395","article-title":"Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study","volume":"8","author":"Critelli","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2019.05.038","article-title":"Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF","volume":"44","author":"Sharma","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0225","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbagen.2013.11.015","article-title":"Frequency decoding of calcium oscillations","volume":"1840","author":"Smedler","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0230","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00424-014-1444-z","article-title":"T-type calcium channels blockers as new tools in cancer therapies","volume":"466","author":"Dziegielewska","year":"2014","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0235","first-page":"1229","article-title":"A role of functional T-type Ca2+ channel in hepatocellular carcinoma cell proliferation","volume":"22","author":"Li","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0240","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10620-015-3633-9","article-title":"Differential expression of ion channels and transporters during hepatocellular carcinoma development","volume":"60","author":"Z\u00fa\u00f1iga-Garc\u00eda","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0245","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1113\/JP271470","article-title":"Age-dependent impact of CaV 3.2 T-type calcium channel deletion on myogenic tone and flow-mediated vasodilatation in small arteries","volume":"594","author":"Mikkelsen","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0250","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ebiom.2019.05.034_bb0255","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/cancers11010110","article-title":"Alternating electric fields (TTFields) activate Cav1.2 channels in human glioblastoma cells","volume":"11","author":"Neuhaus","year":"2019","journal-title":"Cancers"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419303421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419303421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T22:01:41Z","timestamp":1742335301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419303421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"alternative-id":["S2352396419303421"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.034","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2\u202fT-type voltage-gated calcium channels and Ca2+ influx","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.038","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}